Patent · US Active

AAV capsid designs

US11578340B2 · kind B2 · utility

1Cited by

68References

18Claims

0Family size

Assignees

University of Massachusetts · US
Sichuan University · CN

Inventors

Guangping Gao · Rosemont, US
Guangchao Xu · Worcester, US
Phillip Tai · Worcester, US
Yuquan Wei · Chengdu, CN
Li Luo · Worcester, US

Key dates

Filing date	Oct 13, 2017
Grant date	Feb 14, 2023
Priority date	—
Expiry date	Jul 24, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14145
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure in some aspects relates to recombinant adeno-associated viruses having distinct tissue targeting capabilities. In some aspects, the disclosure relates to gene transfer methods using the recombinant adeno-associated viruses. In some aspects, the disclosure relates to isolated AAV capsid proteins and isolated nucleic acids encoding the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.